Wednesday, July 8, 2026

pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG

BRIGHT MINDS BIOSCIENCES

BRIGHT MINDS BIOSCIENCES clinical programs — 116 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

19 Vestry St, New York, NY 10013, US HQ
12 Employees
Public company Type
DRUG · NYSE Ticker
Company details
Status
Public
HQ
19 Vestry St, New York, NY 10013, US
Employees
12
Programs
1063
Drugs
444
Patents
57
Intelligence · Clinical Programs

BRIGHT MINDS BIOSCIENCES projects

116 ClinicalTrials.gov programs sponsored by BRIGHT MINDS BIOSCIENCES.

BRIGHT MINDS BIOSCIENCES has 116 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 3 of 3
  1. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule terminated

    1 trial
  2. Video directly observed therapy with contingency management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other active

    1 trial
  3. Web-based smoking cessation program

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved other completed

    1 trial
  4. XR-B (SUBLOCADETM)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    approved small molecule completed

    1 trial
  5. Xinnaoning Capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Stable Angina Pectoris

    approved small molecule active

    1 trial
  6. brand name metoprolol ER

    BRIGHT MINDS BIOSCIENCES INC.

    Blood Pressure

    approved small molecule completed

    1 trial
  7. buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    3 trials
  8. bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco-Use Disorder

    approved small molecule completed

    1 trial
  9. combination NRT

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial
  10. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    approved other active

    1 trial
  11. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved other completed

    1 trial
  12. medication for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule completed

    1 trial
  13. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial
  14. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial
  15. nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    approved small molecule completed

    2 trials
  16. sIPV+DTaP+MMR

    BRIGHT MINDS BIOSCIENCES INC.

    Vaccine

    approved mab active

    1 trial
  17. sublingual nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial
  18. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial
  19. varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    2 trials
  20. zyban

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does BRIGHT MINDS BIOSCIENCES have?

116 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.